Danforth Health Acquires Asymmetry Group, Expanding Integrated Support for Life Science Commercialization

Danforth Health, announced the acquisition of Asymmetry Group, LLC, strengthening its ability to help scientific innovation reach market and achieve impact for patients.

The acquisition brings 30 seasoned experts in the areas of corporate advisory and commercial strategy, launch planning and execution, and organizational capability building – enhancing the depth and flexibility of Danforth Health’s Commercial & Marketing practice. Founder and Managing Director Greg Lief and Managing Director Yakir Siegal will continue to lead the Asymmetry team.

“Advancing a therapy from development to market requires not only scientific and regulatory achievement, but also early, strategic alignment around commercial goals,” said Chris Connors, CEO of Danforth Health. “Asymmetry Group brings deep expertise in helping companies prepare for and execute successful launches. The team’s insight and experience strengthen our ability to guide clients through one of the most pivotal phases of their journey – delivering innovation to patients.”

Also Read: AiThority Interview with Jonathan Kershaw, Director of Product Management, Vonage

“Joining Danforth Health allows us to bring even greater value to healthcare innovators through an integrated model that aligns commercialization strategy with the full spectrum of development, regulatory, financial, and communications expertise,” said Greg Lief. “Together, we can help life science leaders deliver meaningful innovation with a powerful continuum of support – from early planning and organizational design to brand development, launch execution, and sustained market growth.”

Founded in 2017, Asymmetry Group has built a strong reputation for helping emerging and established life science organizations build, launch, and scale effectively. Its team brings proven experience across corporate strategy, asset commercialization strategy, go-to-market strategy, innovative product launch planning and execution, commercial operations, and organizational capability building – supporting clients as they navigate the complexities of market entry and growth. As part of Danforth Health, these capabilities are available alongside development, clinical, regulatory, and business support for a fully connected solution at every stage of the corporate lifecycle.

This latest acquisition advances Danforth Health’s strategy to build an integrated platform of specialized affiliates – including Danforth Advisors, Advyzom, Argot Partners, Benchworks, Elite BioPharma Consulting, PharmaDirections, and VPMR. The platform is backed by Avesi Partners and united in the mission to empower life science innovation.

Also Read: Why 80% of Organizations Struggle with Agentic AI Despite Massive Investment